Form 4: Elevance Health Executive Charles Morgan Kendrick JR Reports Stock Transactions

Elevance Health's EVP & President, Commercial, Charles Morgan Kendrick JR, reports acquisition and disposal of company stock and stock options on March 1, 2024.

Summary

• Charles Morgan Kendrick JR, an EVP & President, Commercial at Elevance Health, Inc., filed a Form 4 on March 5, 2024, reporting transactions in Elevance Health stock.
• On March 1, 2024, Kendrick disposed of 1,484 shares of common stock to cover tax liabilities at a price of $499.11 per share.
• On the same day, he acquired 2,154 restricted share units and 2,354 performance-based restricted share units at $0.
• Following these transactions, Kendrick directly owns 18,272 shares of Elevance Health common stock.
• Kendrick also acquired an option to purchase 8,312 shares of common stock at an exercise price of $499.11, exercisable in installments starting March 1, 2025.
• Following these transactions, Kendrick directly owns 8,312 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the filing primarily reports routine stock transactions related to executive compensation. There is no indication of significant positive or negative implications for the company.

Positives

• The acquisition of restricted share units and performance-based restricted share units indicates confidence in the company's future performance.
• The granting of stock options to the executive aligns his interests with those of the shareholders.

Future Outlook

The vesting schedule of the restricted share units extends to 2027, and the stock options expire in 2034, suggesting a long-term commitment by the executive to the company's success.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies and are closely monitored by investors for insights into management's confidence in the company's prospects. Form 4 filings are a standard part of regulatory compliance.

Comparison to Industry Standards

• Executive compensation packages, including stock options and restricted stock units, are standard practice in the healthcare industry.
• Companies like UnitedHealth Group (UNH) and Cigna (CI) also utilize similar equity-based compensation to incentivize their executives.
• The vesting schedules and exercise prices are generally aligned with industry norms to retain talent and align executive interests with shareholder value.

Stakeholder Impact

• The transactions have a minor impact on shareholders as they reflect standard executive compensation practices.
• Employees may be indirectly affected by the performance incentives tied to the restricted stock units.

Key Dates